Low CCL2 and CXCL8 Production and High Prevalence of Allergies in Children with Microcephaly Due to Congenital Zika Syndrome

Viruses. 2023 Aug 29;15(9):1832. doi: 10.3390/v15091832.

Abstract

Congenital Zika Syndrome (CZS) is associated with an increased risk of microcephaly in affected children. This study investigated the peripheral dysregulation of immune mediators in children with microcephaly due to CZS. Gene expression quantified by qPCR in whole blood samples showed an increase in IFNγ and IL-13 transcripts in children affected with microcephaly compared to the control group. The microcephaly group exhibited significantly decreased CCL2 and CXCL8 levels in serum, quantified by CBA assay. An allergic profile questionnaire revealed a high prevalence of allergies in the microcephaly group. In accordance, elevated serum IgE level measured by the Proquantum Immunoassay was observed in children affected with microcephaly compared to the control group. Altogether, these findings show a persistent systemic inflammation in children with microcephaly due to CZS and suggest a possible impairment in leukocyte migration caused by low production of CCL2 and CXCL8, in addition to high levels of IgE associated with high prevalence of allergies. The dysregulation of inflammatory genes and chemokines underscores the importance of understanding the immunological characteristics of CZS. Further investigation into the long-term consequences of systemic inflammation in these children is crucial for developing appropriate therapeutic strategies and tailored vaccination protocols.

Keywords: Congenital Zika Syndrome; allergy; chronic inflammation; leukocyte migration; microcephaly.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chemokine CCL2
  • Child
  • Humans
  • Hypersensitivity* / complications
  • Hypersensitivity* / epidemiology
  • Immunoglobulin E
  • Inflammation
  • Microcephaly* / epidemiology
  • Prevalence
  • Zika Virus Infection* / complications
  • Zika Virus Infection* / epidemiology
  • Zika Virus*

Substances

  • CCL2 protein, human
  • Chemokine CCL2
  • Immunoglobulin E
  • CXCL8 protein, human

Grants and funding

This study is funded by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) under grant numbers 304971/2022-7, 311055/2019-2, 431941/2018-1; and by Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP) under grant 2019/25119-7.